Anticancer Activities of PPARγ in Breast Cancer Are Context-Dependent

被引：16

作者：

Dong, Jin-Tang ^{[1
]}

机构：

[1] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA

来源：

AMERICAN JOURNAL OF PATHOLOGY | 2013年 / 182卷 / 06期

关键词：

ACTIVATED-RECEPTOR-GAMMA; ESTROGEN-RECEPTOR; CELLS; MAMMARY; EXPRESSION; AGONISTS; INHIBIT; LIGAND; CARCINOGENESIS; ROSIGLITAZONE;

D O I：

10.1016/j.ajpath.2013.03.005

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：1972 / 1975

页数：4

共 25 条

[1] Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation
Belvisi, MG
Hele, DJ
Birrell, MA
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 533 (1-3) : 101 - 109
[2] Peroxisome proliferator-activated receptor-γ activates p53 gene promoter binding to the nuclear factor-κB sequence in human MCF7 breast cancer cells
Bonofiglio, Daniela
Aquila, Saveria
Catalano, Stefania
Gabriele, Sabrina
Belmonte, Maria
Middea, Emilia
Qi, Hongyan
Morelli, Catia
Gentile, Mariaelena
Maggiolini, Marcello
Ando, Sebastiano
[J]. MOLECULAR ENDOCRINOLOGY, 2006, 20 (12) : 3083 - 3092
[3] Use of the peroxisome proliferator-activated receptor (PPAR) γ ligand troglitazone as treatment for refractory breast cancer:: a phase II study
Burstein, HJ
Demetri, GD
Mueller, E
Sarraf, P
Spiegelman, BM
Winer, EP
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 79 (03) : 391 - 397
[4] Ditsch N, 2012, IN VIVO, V26, P87
[5] Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice
Elstner, E
Müller, C
Koshizuka, K
Williamson, EA
Park, D
Asou, H
Shintaku, P
Said, JW
Heber, D
Koeffler, HP
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) : 8806 - 8811
[6] Peroxisome proliferator-activated receptor γ:: a novel target for cancer therapeutics?
Han, ShouWei
Roman, Jesse
[J]. ANTI-CANCER DRUGS, 2007, 18 (03) : 237 - 244
[7] Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+breast cancer
He, X.
Esteva, F. J.
Ensor, J.
Hortobagyi, G. N.
Lee, M. -H.
Yeung, S. -C. J.
[J]. ANNALS OF ONCOLOGY, 2012, 23 (07) : 1771 - 1780
[8] Herbert BS, 2003, CANCER RES, V63, P1914
[9] Differential anti-proliferative actions of peroxisome proliferator-activated receptor-γ agonists in MCF-7 breast cancer cells
Kim, Ki Young
Kim, Sung Soo
Cheon, Hyae Gyeong
[J]. BIOCHEMICAL PHARMACOLOGY, 2006, 72 (05) : 530 - 540
[10] Antiangiogenic effect of rosiglitazone is mediated via peroxisome proliferator-activated receptor γ-activated maxi-K channel opening in human umbilical vein endothelial cells
Kim, KY
Cheon, HG
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (19) : 13503 - 13512

← 1 2 3 →